BMY vs NVDA: Which Stock is Better?
Side-by-side comparison of Bristol Myers Squibb Co and Nvidia Corp in 2026
Comparison Updated:
BMY
Bristol Myers Squibb Co
$0.00
NVDA
Nvidia Corp
$184.91
Key Metrics Comparison
| Metric | BMY | NVDA | Winner |
|---|---|---|---|
| Market Cap | $0.00M | $4.49T | NVDA |
| P/E Ratio | N/A | N/A | Tie |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze BMY
Full quant analysis
Analyze NVDA
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is BMY or NVDA a better investment?
Comparing BMY and NVDA: Bristol Myers Squibb Co has a market cap of $0.00M while Nvidia Corp has $4.49T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between BMY and NVDA?
BMY (Bristol Myers Squibb Co) and NVDA (Nvidia Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: BMY or NVDA?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.